Revista de la OFIL
ISSN 1699-714X ISSN 1131-9429
TEJEDOR-TEJADA, E; ANDRADE-ANDRADE, I; NOGUERAS-MORILLAS, MA MUNOZ-FERNANDEZ, C. Management of multiple sclerosis outbreak in the home setting. []. , 32, 3, pp.291-293. 25--2023. ISSN 1699-714X. https://dx.doi.org/10.4321/s1699-714x20220003000013.
Objective:
To evaluate the efficacy and safety of a treatment for multiple sclerosis (MS) flares alternative to the conventional method, the intravenous route.
Method:
Observational and retrospective, during the months of July-Novembre 2020, coinciding with the period of mobility limitation in Spain due to SARSCoV-2. The sample included 7 patients. The variables were: sex, age, type of MS, result on the expanded disability scale (EDSS), treatment, symptoms and evolution. The programs used were: patient history, outpatient dispensing and magnetic resonance imaging (MRI).
Results:
The results of 7 patients with a mean age of 44.85±13 years were measured. All with a diagnosis of relapsing remitting MS. The mean EDSS score was 3. The main symptoms referred to were: paresthesia, muscle weakness and urinary incontinence. 85% ofthe patients evolved favorably. Anotheraspect that stands out is the comfort ofthe patient from home instead of goingto the hospital.
Discussion and conclusion:
Oral administration of 1,400 mg prednisone for 5 days is a safe, effective and comfortable alternative as a treatment for acute outbreaks in multiple sclerosis. The objective was to evaluate the efficacy and safety of an alternative treatment for MS flares to the conventional method, the intravenous route.
: Multiplesclerosis; steroid; hospital pharmacy.